VIRTUAL WORKING GROUP MEETING
Monday, July 26, 2021
1:15 - 3:15 pm
ZOOM
Presentations and Open Forum will discuss the optimal MS-based analyte identification criteria. A collaborative study of multiple matrices and analytes is being planned to evaluate analyte identification criteria to minimize the rate of false positives and false negatives.
Goals of the NACRW Veterinary Drugs Working Group
2021 MEETINGS
Virtual meeting
Reviewed study parameters, discussed introductory letter and "Call for Participants"; began developing a list of international laboratories who might participate; prepare protocol for first round.
Virtual meeting
Discussed introductory letter and "Call for Participants"; began developing a list of official control international laboratories who might participate; prepare protocol for first round.
Virtual meeting
Draft introductory letter reviewed; added international, E.U. and U.S. labs to invitation list; reviewed website content, drafted content for Meeting at a Glance, reviewed collaborative study timeline, began preparing protocol for first round.
Virtual meeting
Finalize list of potential participants and letter advertising the study. Begin drafting protocol for 1st round of collaborative study. Approve abstract and agenda for July Working Group annual meeting.
2019-2020 MEETINGS
Met at NACRW.
Discuss future work to evaluate the performance of multi-analyte veterinary drug methods useful for regulatory laboratories.
Met at AOAC. New members identified.
Discuss definition of multi-residue/multi-class methods.
Propose subgroup to develop a collaborative study.
Virtual meeting
Review performance requirements for multi-residue methods.
Discuss possible collaborative study.
Virtual meeting
Subgroup reviews proposed collaborative study protocol
Virtual meeting
Subgroup proposes top 30 analytes to be studied in collaborative study.
Virtual meeting
Subgroup discusses details of proposed collaborative study including instruments, matrices, number of replicates, laboratories willing to prepare samples and data to be provided by participating laboratories.
Virtual meeting
NACRW meeting cancelled.
Virtual meeting
Subgroup meets to continue discussion of collaborative study specifics.
Virtual meeting
Subgroup discusses the analytes and concentrations for each matrix.
Virtual meeting
Subgroup assigns the collaborative study threshold concentrations for Top30 analytes in matrices (eggs, kidneys, meats, milks, livers, fishes).
2019-2020 MEETINGS
Met at NACRW.
Discuss future work to evaluate the performance of multi-analyte veterinary drug methods useful for regulatory laboratories.
Met at AOAC. New members identified.
Discuss definition of multi-residue/multi-class methods.
Propose subgroup to develop a collaborative study.
Virtual meeting
Review performance requirements for multi-residue methods.
Discuss possible collaborative study.
Virtual meeting
Subgroup reviews proposed collaborative study protocol
Virtual meeting
Subgroup proposes top 30 analytes to be studied in collaborative study.
Virtual meeting
Subgroup discusses details of proposed collaborative study including instruments, matrices, number of replicates, laboratories willing to prepare samples and data to be provided by participating laboratories.
Virtual meeting
NACRW meeting cancelled.
Virtual meeting
Subgroup meets to continue discussion of collaborative study specifics.
Virtual meeting
Subgroup discusses the analytes and concentrations for each matrix.
Virtual meeting
Subgroup assigns the collaborative study threshold concentrations for Top30 analytes in matrices (eggs, kidneys, meats, milks, livers, fishes).
PLEASE CONTACT THE CHAIRS FOR MORE INFORMATION
Eric Verdon,
Sherri Turnipseed
Copyright © 2021(FLAG Works, Inc./NACRW) All Rights Reserved.